Forbes - Ends at Midnight
|
||||||||||||||||||
Older messages
Bitcoin Undervalued? | Flush VCs Still Making Web3 Bets
Saturday, May 28, 2022
Also: Bitcoin Miners Face Shrinking Profitability Amid Crypto Crash Also: Bitcoin Miners Face Shrinking Profitability Amid Crypto Crash View in browser IN THE DEPTHS OF A BEAR MARKET On early Thursday,
Crypto is not for everyone; but it might be for you
Saturday, May 28, 2022
Don't sit this one out. The time to claim your million–dollar future is now. View in browser Fellow Investor, I know crypto assets like bitcoin have been on a wild ride lately. It's worth
Psst…we’re working on something new!
Thursday, May 26, 2022
We're making big changes to our newsletter. A Note From Kelly Anne A bigger, brighter newsletter will soon be winging its way to you A few weeks ago, we paused our newsletter to make big
Last Chance to Register—How to Build a Crypto Portfolio Amid Market Turbulence
Tuesday, May 24, 2022
Join us TODAY at 2PM EST LIVE WEBINAR We're just a few hours away from our much-anticipated event, How to Build a Crypto Portfolio Amid Market Turbulence, but we noticed you still haven't
⏰ Time Is Running Out To Register: How to Build a Crypto Portfolio Amid Market Turbulence
Monday, May 23, 2022
Join us tomorrow, May 24th at 2PM EST LIVE WEBINAR We're only 24 hours away from our much-anticipated event, How to Build a Crypto Portfolio Amid Market Turbulence, but we noticed you haven't
You Might Also Like
Full-crime job
Friday, April 26, 2024
Lawyers for Trump argued before SCOTUS that the president has "total immunity" ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
All of My Friends Have These Sweatpant Jeans
Friday, April 26, 2024
Here's What You Missed on the Strategist The Strategist Every product is independently selected by editors. If you buy something through our links, New York may earn an affiliate commission. All of
🌈 Live a bold & bright life
Friday, April 26, 2024
Introducing our theme for May plus fun stuff to read, watch, and click on curated by CreativeMornings HQ. April 25, 2024 Open in new tab Did a friend forward this? Subscribe today! Speech bubble logo
🕐 Time Is Running Out: Your $99 Offer Expires In 48 Hours
Thursday, April 25, 2024
This advisory has returned a massive 838% since inception compared to the 273% return from the S&P 500 Final 48 Hours Fellow Investor, We recently sent you an exclusive offer to try our flagship
The Professor Protesting Columbia’s Own Students
Thursday, April 25, 2024
Columns and commentary on news, politics, business, and technology from the Intelligencer team. Intelligencer THURSDAY, APRIL 25 The Professor Protesting Columbia's Own Students Shai Davidai, a
Before you lose your phone ...
Thursday, April 25, 2024
Do these things now ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Friday Briefing: Supreme Court hears Trump immunity case
Thursday, April 25, 2024
Also, more bodies found in a Gazan mass grave. View in browser|nytimes.com Continue reading the main story Ad Morning Briefing: Asia Pacific Edition April 26, 2024 Author Headshot By Amelia Nierenberg
Microsoft results beat quarterly expectations as profits rise 20% to nearly $22B
Thursday, April 25, 2024
Breaking News from GeekWire GeekWire.com | View in browser BREAKING NEWS Microsoft posted a 17% increase in revenue, to $61.9 billion, with $21.9 billion in profits, up 20%, and earnings of $2.94 per
The Dark Side of Immune
Thursday, April 25, 2024
SCOTUS and Why It's Good to be the King ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Techie-turned-lawmaker uses Microsoft chops as state senator | ‘Acquired’ podcast hosts raising fund
Thursday, April 25, 2024
Amazon to stream Seattle Kraken games | Impinj stock soars | 'Good to Go!' scam warning ADVERTISEMENT GeekWire SPONSOR MESSAGE: Science Firsthand: Learn how Bristol Myers Squibb unlocked the